ARTICLE | Company News
Chesapeake PERL, U.S. Department of Defense neurology, biomanufacturing news
October 29, 2012 7:00 AM UTC
DoD's Defense Threat Reduction Agency (DTRA) awarded Chesapeake a contract to develop a recombinant butyrylcholinesterase (BChE) as a nerve agent countermeasure. The contact will fund development and...